Aurobindo Pharma (Aurobindo) has received the final approval for Risperidone Oral Solution 1mg/ml (ANDA No. 78-452) from the FDA. Risperidone Oral Solution 1mg/ml is generic equivalent to Risperdal
Speciality European Pharma (SEP) has launched Regurin XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) in the UK. Regurin XL is licensed
Meda and Cipla have expanded the existing long term collaboration agreement for the combination of azelastine and fluticasone. Azelastine is an antihistamine and fluticasone a corticosteroid, indicated for
Suven Life Sciences (Suven) has received its first milestone payment in drug discovery collaboration with Eli Lilly. The milestone was achieved with the identification and selection of a
Can-Fite BioPharma (Can-Fite) has reported that its 75-patient phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.
Sanofi Pasteur, the vaccines division of Sanofi-aventis, has signed an agreement with Butantan Institute for the production and supply of a vaccine against the new A(H1N1) influenza virus
French healthcare diagnostics group, bioMerieux, reported an increase in sales by 11.6% to E589.5m from E528.2m for the first-half of previous year. bioMerieux posted net profit in the
The FDA has notified Cell Therapeutics (CTI) that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review, has been established regarding
Biogen Idec has submitted a proposal to the Board of Directors of Facet Biotech Corporation to acquire all of the outstanding shares of Facet for $14.50 per share
Karolinska Development has announced that one of its portfolio companies, Dilafor, has concluded an extensive clinical study of its candidate drug, tafoxiparin, a new drug substance for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.